A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer

被引：0
|
作者：
Ramesh K. Ramanathan
Joel Picus
Haralambos Raftopoulos
Stephen Bernard
A. Craig Lockhart
Gary Frenette
John Macdonald
Susan Melin
Daniel Berg
Frank Brescia
Howard Hochster
Allen Cohn
机构：
[1] University of Pittsburgh School of Medicine,Division of Hematology/Oncology, Department of Medicine
[2] Washington School of Medicine,Department of Internal Medicine, Division of Hematology/Oncology
[3] Columbia University Medical Center,undefined
[4] University of North Carolina,undefined
[5] Chapel Hill,undefined
[6] Vanderbilt University Medical Center,undefined
[7] Carolinas Hematology–Oncology Associates,undefined
[8] Saint Vincent’s Comprehensive Cancer Center,undefined
[9] Aptium Oncology,undefined
[10] Wake Forest University,undefined
[11] University of Iowa,undefined
[12] Medical University of South Carolina,undefined
[13] New York University School of Medicine,undefined
[14] Rocky Mountain Cancer Center,undefined
[15] UPMC Cancer Pavilion,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 61卷
关键词：
Colorectal cancer; Phase II; Milataxel; MAC-321; Taxanes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：453 / 458
页数：5
相关论文
共 50 条
  • [31] Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane
    Hironaga Satake
    Tamotsu Sagawa
    Koshi Fujikawa
    Yukimasa Hatachi
    Hisateru Yasui
    Masahito Kotaka
    Takeshi Kato
    Akihito Tsuji
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 839 - 845
  • [32] Phase II study of flavopiridol in patients with advanced colorectal cancer
    Aklilu, M
    Kindler, HL
    Donehower, RC
    Mani, S
    Vokes, EE
    ANNALS OF ONCOLOGY, 2003, 14 (08) : 1270 - 1273
  • [33] Phase II trial of weekly paclitaxel in patients with previously treated advanced urothelial cancer
    Vaughn, DJ
    Broome, CM
    Hussain, M
    Gutheil, JC
    Markowitz, AB
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) : 937 - 940
  • [34] Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study
    Malmstrom, Annika
    Hansen, Jorgen
    Malmberg, Lena
    Carlsson, Lena
    Svensson, Jan-Henry
    Ahlgren, Johan
    Ahlin, Cecila
    Jansson, Tomas
    Westberg, Ronny
    ACTA ONCOLOGICA, 2010, 49 (01) : 35 - 41
  • [35] Phase II study of oxaliplatin, capecitabine, and irinotecan (OCI) in patients (pts) with previously untreated advanced colorectal cancer
    Pavia, OA
    Cangiano, J
    Crisostomo, R
    Caceres, W
    Barranco, E
    Wright, M
    Antonia, T
    Antonia, S
    Sullivan, D
    Garrett, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 307S - 307S
  • [36] Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancer
    Kuo, T
    Cho, CD
    Halsey, J
    Wakelee, HA
    Advani, RH
    Ford, JM
    Fisher, GA
    Sikic, BI
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5613 - 5619
  • [37] TREATMENT PATTERNS AMONG PATIENTS WITH ADVANCED BREAST CANCER PREVIOUSLY TREATED WITH AN ANTHRACYCLINE AND A TAXANE: A RETROSPECTIVE LONGITUDINAL STUDY
    Colman, S.
    Strizek, A.
    O'Leary, B. A.
    Ruth, A. J.
    Cook, G. A.
    VALUE IN HEALTH, 2009, 12 (07) : A290 - A290
  • [38] Phase II Study of Dasatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Kelley, Michael J.
    Jha, Gautam
    Shoemaker, Debra
    Herndon, James E., II
    Gu, Lin
    Barry, William T.
    Crawford, Jeffrey
    Ready, Neal
    CANCER INVESTIGATION, 2017, 35 (01) : 32 - 35
  • [39] A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer
    Bando, Hideaki
    Shimodaira, Hideki
    Fujitani, Kazumasa
    Takashima, Atsuo
    Yamaguchi, Kensei
    Nakayama, Norisuke
    Takahashi, Takehiro
    Oki, Eiji
    Azuma, Mizutomo
    Nishina, Tomohiro
    Hironaka, Shuichi
    Komatsu, Yoshito
    Shitara, Kohei
    EUROPEAN JOURNAL OF CANCER, 2018, 91 : 86 - 91
  • [40] Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib
    Lee, Dae-Won
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Kim, Tae-Yong
    Han, Sae-Won
    Oh, Youn
    Im, Seock-Ah
    Kim, Tae-You
    Lee, Youngeun
    Kim, Haeryoung
    Lee, Kyung-Hun
    CLINICAL CANCER RESEARCH, 2021, 27 (03) : 713 - 718
12345